<DOC>
	<DOCNO>NCT01071187</DOCNO>
	<brief_summary>The varenicline alcohol dependence trial investigates efficacy varenicline versus placebo maintain abstinence postacute treatment alcohol dependent subject . The main study hypothesis subject treat varenicline abstinent day study .</brief_summary>
	<brief_title>Varenicline Alcohol Dependence</brief_title>
	<detailed_description />
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>diagnosis alcohol dependence accord DSM IV inpatient outpatient last alcohol consumption within 721 day randomisation subject must go detoxification program must free withdrawal symptom randomisation diagnosis nicotine dependence accord DSM IV sufficient knowledge german language subject able follow verbal write instruction subject enable consent ability subject understand character individual consequence clinical trial sign date informed consent subject must bei available start specific trial procedure subject must clearly state desire stay abstinent woman postmenopausal two year woman childbearing potential practicing two year participate study alcohol withdrawal delirium last alcohol detoxification alcohol induce dementia severe renal insufficiency detoxification subject ` woman pregnant breastfeed plan become pregnant trial woman childbearing potential practicing medically accept contraception trial subject know psychiatric disorder require treatment include major depressive disorder , substance dependence abuse ( besides nicotine , alcohol cannabis ) psychosis dissocial personality disorder accord DSMIV elevate suicide risk , define one positive question suicide section MiniInternational Neuropsychiatric Interview ( M.I.N.I . ) subject acute depression , define HAMD17 ( german version ) sum score &gt; 9 BDI ( german version ) sum score &gt; 12 clinically relevant acute chronic progressive neurologic , gastrointestinel , cardiovascular , hepatic , renal , hematological , endocrine , dermatological respiratory disease severe infection , alcoholinduced hepatitis uncontrolled arterial hypertension use medication effect alcohol consumption within 14 day study initiation include antidepressant , antipsychotic , anticonvulsives , benzodiazepine ( besides give contect detoxification program , anticraving drug naltrexone , acamprosate disulfiram nicotine substitute subject follow lab parameter : AST upper fivehold normal limit , PTT &lt; 50 % , leucocytes &lt; 2/nl , haemoglobin &lt; 9g/dl , thrombocytes &lt; 80/nl , creatinine &gt; 1,5mg/dl creatinine clearance &lt; 30ml/min history cancer 5 last year know allergy ingredient study drug history myocardial infarction stroke participation clinical trial last 90 day prior screen clinically relevant visual disturbance ear disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>alcohol dependence</keyword>
	<keyword>addiction</keyword>
	<keyword>alcohol</keyword>
	<keyword>relapse prevention</keyword>
</DOC>